Kopran
Ticker >

Kopran share price

Kopran Ltd.

NSE: KOPRAN BSE: 524280 SECTOR: Pharmaceuticals & Drugs  44k   135   26

257.40
0 0
BSE: 19 Apr 04:01 PM

Price Summary

Today's High

₹ 260.8

Today's Low

₹ 245.75

52 Week High

₹ 292.4

52 Week Low

₹ 140

FinStar

Ownership Below Par
Stock price may face volatility due to ownership structure.
ValuationFair
The stock’s market price justifies its intrinsic value.
EfficiencyPoor
The company seems highly inefficient in case of asset management.
FinancialsVery Stable
The company possesses stable growth history and manageable debt.
*It is just an analytical rating of the company and not an investment advice.

Company Essentials

Market Cap

₹ 1240.94 Cr.

Enterprise Value

₹ 1266.23 Cr.

No. of Shares

4.82 Cr.

P/E

49.95

P/B

3.1

Face Value

₹ 10

Div. Yield

1.17 %

Book Value (TTM)

₹  83.07

CASH

₹ 2.59 Cr.

DEBT

₹ 27.88 Cr.

Promoter Holding

44.49 %

EPS (TTM)

₹  5.15

Sales Growth

33.53%

ROE

8.07 %

ROCE

9.44%

Profit Growth

166.11 %

Add Your Ratio

* Total debt includes long term borrowing, short term borrowing plus current maturities of long-term borrowing
* Ratios are based on latest Audited Financial Result.

Your Added Ratios

Please login to Add & View your own added ratios.

Login

Price Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

 

Volume Chart 1d 1w 1m 3m 6m 1Yr 3Yr 5Yr

* Prices are based on daily market changes.

PE Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

PB Chart 1w 1m 3m 6m 1Yr 3Yr 5Yr

* The chart is based on the standalone earnings of the company. * Negative values and values more than 1000x in PE chart is considered 0.

Peer Comparison

View Full Peer Comparison
* The Peers list includes companies operating in the same industry and having comparable market cap.

 Group Companies

Track the companies of Group.

Ratios

Sales Growth

1 Year33.53%
3 Year15.06%
5 Year12.18%

Profit Growth

1 Year166.11%
3 Year40.7%
5 Year46.03%

ROE%

1 Year8.07%
3 Year7.23%
5 Year6.56%

ROCE %

1 Year9.44%
3 Year9.55%
5 Year9.06%

Debt/Equity

0.0705

Price to Cash Flow

73.57

Interest Cover Ratio

14.8170827562975

CFO/PAT (5 Yr. Avg.)

0.547628397025376

Share Holding Pattern

Promoter Pledging %

Date Promoter % Pledge %
Mar 2024 44.49 0
Dec 2023 44.51 0
Sep 2023 44.49 0
Jun 2023 44.49 0
Mar 2023 44.3 0
Investors List
* Figures given above are % of equity capital

 Strengths

  • The company has shown a good profit growth of 40.7023245308467% for the Past 3 years.
  • The company has shown a good revenue growth of 15.0582769729654% for the Past 3 years.
  • Company is virtually debt free.
  • Company has a healthy Interest coverage ratio of 14.8170827562975.
  • Company’s PEG ratio is 0.300686144499857.
  • The company has an efficient Cash Conversion Cycle of 47.5363376465841 days.
  • The company has a strong degree of Operating leverage, Average Operating leverage stands at 3.93431516632419.

 Limitations

  • Company has a poor ROE of 7.22622142276535% over the past 3 years.
  • The company is trading at a high EV/EBITDA of 32.1079.

Quarterly Result (All Figures in Cr.)

PARTICULARS Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023
Net Sales 67.96 80.23 65.86 98.64 82.33
Total Expenditure 61.86 72.87 65.04 89.94 70.27
Operating Profit 6.1 7.36 0.82 8.7 12.06
Other Income 1.16 2.07 1.48 5.79 1.29
Interest 0.72 0.84 0.95 0.75 1.03
Depreciation 1.12 1.09 1.12 1.16 1.17
Exceptional Items 0 0 0 0 0
Profit Before Tax 5.42 7.51 0.23 12.58 11.16
Tax 1.38 1.99 0.07 1.92 2.65
Profit After Tax 4.04 5.52 0.15 10.66 8.51
Adjusted EPS (Rs) 0.84 1.14 0.03 2.21 1.77

Profit & Loss (All Figures in Cr. Adjusted EPS in Rs.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Net Sales 196.65 179.29 222.83 204.52 273.09
Total Expenditure 173.95 156.11 192.68 189.26 245.18
Operating Profit 22.7 23.18 30.15 15.26 27.91
Other Income 3.22 1.99 10.46 8.18 16.09
Interest 5.46 5.96 3.81 2.95 2.67
Depreciation 3.11 3.47 4.1 4.32 4.41
Exceptional Items 0 0 0 0 0
Profit Before Tax 17.36 15.73 32.71 16.16 36.92
Tax 4.39 4.51 9.23 4.42 5.66
Net Profit 12.97 11.22 23.47 11.74 31.25
Adjusted EPS (Rs.) 3 2.59 5.43 2.44 6.48

Balance Sheet (All Figures are in Crores.)

Particulars Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Equity and Liabilities
Share Capital 43.25 43.25 43.25 48.21 48.21
Total Reserves 175.19 186.42 203.6 330.51 347.38
Borrowings 21.71 9.67 2.36 2.08 2.3
Other N/C liabilities 0.65 2.64 6.17 7.07 7.18
Current liabilities 74.81 83.87 68.57 76.25 100.88
Total Liabilities 315.61 325.85 323.95 464.12 505.95
Assets
Net Block 41.88 42.95 47.44 46.22 47.35
Capital WIP 0.94 0.94 0 0 0
Intangible WIP 5.82 6.13 2.82 3.1 3.53
Investments 157.52 158.14 158.79 259.43 260.07
Loans & Advances 1.93 3.38 3.74 3.92 4.1
Other N/C Assets 0.11 0.08 0.04 0.14 0.49
Current Assets 107.42 114.23 111.12 151.31 190.41
Total Assets 315.61 325.85 323.95 464.12 505.95
* Other Non-current Liabilities include Net deferred Liabilities

Cash Flows (All Figures are in Crores.)

PARTICULARS Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Profit from operations 17.36 15.73 32.71 16.16 36.92
Adjustment 3.32 11.64 7.38 4.17 -9.04
Changes in Assets & Liabilities -4.9 -13.53 14.1 -54.53 -4.68
Tax Paid -3.94 -3.87 -5.41 -3.61 -6.32
Operating Cash Flow 11.84 9.97 48.77 -37.8 16.87
Investing Cash Flow -4.47 0.63 -8.51 -100.26 10.05
Financing Cash Flow -7.43 -10.6 -40.14 137.99 -26.13
Net Cash Flow -0.06 0 0.12 -0.07 0.79

Corporate Actions

Investors Details

PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
promoters 44.30 44.49 44.49 44.51 44.49
g.claridge & company limi... 0.71 0.71 0.71 0.71 0.71
hazarimall somani 0.04 0.04 0.04 0.04 0.04
hridai susheel somani 0.24 0.24 0.24 0.24 0.24
jaya somani 0.54 0.54 0.54 0.54 0.54
kopran lifestyle limited 0.01 0.01 0.01 0.01 0.01
mr adarsh somani 0.38 0.38 0.38 0.38 0.38
mridula somani 1.04 1.64 1.64 1.64 1.64
nupur somani 0.56 0.56 0.56 0.56 0.56
oricon enterprises ltd 12.90 12.90 12.90 12.90 12.90
panorama finvest pvt ltd 7.88 7.88 7.88 7.88 7.88
parijat shipping and fina... 0.80 0.80 0.80 0.80 0.80
rajendra somani 4.26 3.66 3.66 3.66 3.66
sarvamangal mercantile co... 6.02 6.02 6.02 6.02 6.02
somani kumkum 0.07 0.07 0.07 0.07 0.07
suhrid somani 0.19 0.19 0.19 0.19 0.19
surendra somani 1.04 1.24 1.24 1.24 1.24
susheel somani 1.81 1.81 1.81 1.81 1.81
united shippers ltd 4.56 4.56 4.56 4.56 4.56
vandana somani 0.67 0.67 0.67 0.67 0.67
varun somani 0.57 0.57 0.57 0.57 0.57
PARTICULARS Mar 2023% Jun 2023% Sep 2023% Dec 2023% Mar 2024%
investors 55.70 55.51 55.51 55.49 55.51
laxminarayan vyapaar p lt... 1.96 1.95 1.95 1.95 1.95
madhuri madhusudan kela - 1.04 1.04 1.04 1.04
viraj russell mehta 1.85 1.85 1.85 1.85 1.85
madhuri madhusudan kela .... 1.04 - - - -

Annual Reports

Ratings & Research Reports

Company Presentations

  • ConcallQ2FY24 27 Nov 2023
  • PresentationQ4FY22 21 Jun 2022
  • PresentationQ4FY21 11 Jun 2021
  • PresentationQ3FY24 10 Feb 2024
  • PresentationQ3FY21 20 May 2021
  • PresentationQ2FY21 9 Nov 2020

Company News

Kopran informs about details of loss of certificate 19 Mar 2024, 1:01PM Kopran - Quaterly Results7 Feb 2024, 1:42PM Kopran - Quaterly Results7 Feb 2024, 1:42PM Kopran - Quaterly Results7 Feb 2024, 1:42PM Kopran informs about loss of share certificate17 Jan 2024, 5:19PM Kopran informs about issue of duplicate share certificate21 Nov 2023, 3:04PM Kopran informs about loss of share certificate 17 Nov 2023, 5:15PM Kopran - Quaterly Results7 Nov 2023, 1:34PM Kopran - Quaterly Results7 Nov 2023, 1:34PM Kopran - Quaterly Results7 Nov 2023, 1:34PM Kopran informs about board meeting26 Oct 2023, 2:40PM Kopran informs about issuance of duplicate share certificate19 Oct 2023, 2:35PM Kopran informs about details of loss of certificate6 Oct 2023, 4:23PM Kopran informs about closure of trading window26 Sep 2023, 4:48PM Kopran informs about loss of share certificate22 Sep 2023, 5:22PM Kopran informs about details of loss of certificate 11 Sep 2023, 4:39PM Kopran - Quaterly Results10 Aug 2023, 12:51PM Kopran - Quaterly Results10 Aug 2023, 12:51PM Kopran - Quaterly Results10 Aug 2023, 12:51PM Kopran - Quaterly Results25 May 2023, 3:15PM Kopran - Quaterly Results25 May 2023, 3:15PM Kopran - Quaterly Results25 May 2023, 3:15PM Kopran informs about PCS certificate21 Apr 2023, 4:37PM Kopran informs about details of loss of certificate23 Feb 2023, 4:50PM Kopran informs about issuance of duplicate share certificates18 Feb 2023, 10:58AM Kopran informs about newspaper publication13 Feb 2023, 5:09PM Kopran - Quaterly Results10 Feb 2023, 2:15PM Kopran - Quaterly Results10 Feb 2023, 2:15PM Kopran - Quaterly Results10 Feb 2023, 2:15PM Kopran informs about details of loss of certificate24 Jan 2023, 4:44PM Kopran informs about details of loss of certificate3 Jan 2023, 5:01PM Kopran informs about loss of share certificate13 Dec 2022, 2:20PM Kopran informs about details of loss of certificate 7 Dec 2022, 3:40PM Kopran - Quaterly Results11 Nov 2022, 4:49PM Kopran - Quaterly Results11 Nov 2022, 4:49PM Kopran informs about board meeting 1 Nov 2022, 4:46PM Kopran - Quaterly Results10 Aug 2022, 1:31PM Kopran - Quaterly Results10 Aug 2022, 1:31PM Kopran - Quaterly Results10 Aug 2022, 1:31PM Kopran submits annual report6 Aug 2022, 2:42PM Kopran informs about certificate 13 Jul 2022, 4:57PM Kopran informs about loss of share certificates29 Jun 2022, 5:03PM Kopran informs about loss of share certificate24 Jun 2022, 4:36PM Kopran - Quaterly Results27 May 2022, 3:37PM Kopran - Quaterly Results27 May 2022, 3:37PM Kopran informs about board meeting13 May 2022, 3:55PM Kopran informs about issuance of duplicate share certificate23 Apr 2022, 11:55AM Kopran informs about certificate7 Apr 2022, 4:15PM Kopran informs about loss of share certificate10 Mar 2022, 3:07PM Kopran informs about loss of share certificate8 Mar 2022, 5:05PM

Kopran Stock Price Analysis and Quick Research Report. Is Kopran an attractive stock to invest in?

 

The Indian healthcare sector is expected to reach US$ 372 billion by 2022, driven by rising incomes, greater health awareness, lifestyle diseases and increasing access to insurance. Healthcare has become one of India’s largest sectors - both in terms of revenue and employment.

Healthcare comprises hospitals, medical devices, clinical trials, outsourcing, telemedicine, medical tourism, health insurance, and medical equipment. The structure of the healthcare delivery system in India consists of three broad segments: Primary care, Secondary care, and Tertiary care.

  • Primary care is the first point of contact between the population and the healthcare service providers. For example, Sub-center (SC), Primary Health Centre (PHC) and Community Health Centre (CHC) which is more relevant to rural areas (PHC’s).
  • Secondary care providers inpatient as well as outpatient medical services and includes simple surgical procedures. For example, District level & Mid-sized hospitals.
  • Tertiary care is the third level of the healthcare delivery system in the country. These hospitals are specialized consultative healthcare infrastructure. For example, Single specialty and Multi-specialty hospitals.

While healthcare services are offered by the public as well as private sectors, in urban as well as rural areas, generally people prefer private hospitals over public hospitals for treatment of diseases, illness, and sickness. So, let’s look into Kopran and its performance over the period of time.

  • Operating cash flow ratio: It measures the adequacy of a company’s cash generated from operating activities to pay off short-term financial obligations. Kopran cash from the operating activity was Rs 16.868 Cr.
     
  • Financial Strength: Health care organizations usually have high debt loads and low equity capital in their balance sheet. So, Debt to Equity ratio is important to analyze the company’s sustainability. Kopran has a Debt to Equity ratio of 0.0705 , which is a strong indication for the company.
     
  • EPS growth: Investors should ensure the EPS figure is growing faster than revenue numbers because it indicates company management is increasing the efficiency with which it runs the company. In Kopran , the EPS growth was 166.11658456486 % which is good for the company.
     
  • Operating profit margin: It determines a company's potential earnings. It assesses how well-managed a company with respect to its basic overhead costs and other operating expenses, Kopran has OPM of 10.2210294740142 % which is a bad sign for profitability.
     
  • ROE: Kopran have a poor ROE of 8.07242055996916 %. ROE is an important financial parameter for hospitals & health care companies because they expand and grow rapidly. Therefore, ROE measures how efficiently a shareholder's fund is used for generating profits.
     
  • Share Price: - The current share price of Kopran is Rs 257.05. One can use valuation calculators of ticker to know if Kopran share price is undervalued or overvalued.
Last Updated on:
Brief about Kopran

Kopran Limited Financials: Check Share Price, Balance Sheet, Annual Report, Quarterly Results, Shareholding, Company Profile and News for Company Analysis

Kopran Limited is a leading pharmaceutical company in India, dedicated to manufacturing and marketing a wide range of healthcare products. With a rich history of over three decades, Kopran has emerged as a trusted brand in the pharmaceutical industry. The company focuses on developing and producing high-quality generic medicines, active pharmaceutical ingredients (APIs), and over-the-counter (OTC) products.

Share Price - Kopran Limited

Kopran Limited's share price reflects the market valuation of the company's stock. The share price is influenced by various factors such as the company's financial performance, industry trends, and market sentiment. As a long-term stock investor, it is crucial to analyze the share price movement to make informed investment decisions. Our pre-built screening tools allow you to track and analyze the share price of Kopran Limited over time, enabling you to identify potential investment opportunities.

Balance Sheet - Kopran Limited

The balance sheet provides a snapshot of a company's financial position, representing its assets, liabilities, and shareholders' equity. Kopran Limited's balance sheet showcases the company's financial stability and growth prospects. Utilizing our premium features, such as DCF Analysis, BVPS Analysis, Earnings multiple approach, and DuPont analysis, investors can calculate the fair value of Kopran Limited's stock based on the balance sheet data. These tools enable investors to assess the company's intrinsic value and make informed investment decisions.

Annual Report - Kopran Limited

The annual report of Kopran Limited provides comprehensive insights into the company's performance, achievements, and future prospects. Our website offers downloadable annual reports for Kopran Limited, allowing investors to analyze the company's financials, management discussions, and outlook. By studying the annual report, investors can gain a deeper understanding of Kopran Limited's business strategies and make informed investment decisions.

Dividend - Kopran Limited

Kopran Limited has a history of rewarding its shareholders through dividends. Dividends are a portion of the company's profits distributed among its shareholders. Monitoring the dividend payout and dividend yield of Kopran Limited can be crucial for long-term investors seeking regular income from their investments. By utilizing our pre-built screening tools, investors can easily track the dividend history and dividend yield of Kopran Limited, helping them make investment decisions aligned with their income goals.

Quarterly Result - Kopran Limited

The quarterly results of Kopran Limited provide updated information on the company's financial performance during a specific three-month period. Investors can evaluate the company's revenue growth, profitability, and other key financial metrics by analyzing the quarterly results. Our website offers quarterly result updates for Kopran Limited, allowing investors to stay informed and assess the company's ongoing performance.

Stock Price - Kopran Limited

The stock price of Kopran Limited represents the market value of the company's shares. Tracking the stock price movement is essential for investors to gauge market sentiment and assess the performance of their investment. Our website provides a price chart that displays the historical stock price movement of Kopran Limited, enabling investors to identify trends and patterns, aiding in their analysis and decision-making process.

News - Kopran Limited

Staying updated with the latest news and developments related to Kopran Limited is crucial for investors. Our website provides a dedicated news section for Kopran Limited, where investors can access relevant news articles, press releases, and corporate announcements. By keeping abreast of the news, investors can stay informed about the company's activities, industry trends, and market dynamics, supporting their investment analysis.

Concall Transcripts - Kopran Limited

Concall transcripts provide valuable insights into the discussions and Q&A sessions that take place during the company's earnings conference calls. Our website offers downloadable concall transcripts for Kopran Limited, allowing investors to read and analyze the discussions between the company's management and analysts. By studying these transcripts, investors can gain a deeper understanding of the company's performance, growth strategies, and future outlook.

Investor Presentations - Kopran Limited

Investor presentations are a valuable resource for understanding a company's business model, growth plans, and financial performance. Kopran Limited provides investor presentations that offer a comprehensive overview of the company's operations, market position, and future prospects. By accessing these downloadable presentations on our website, investors can delve into the details and make informed investment decisions.

Promoters - Kopran Limited

The promoters of Kopran Limited play a crucial role in shaping the company's vision, strategic direction, and overall growth. Our website provides information about the key promoters of Kopran Limited, including their background, experience, and contribution to the company's success. By understanding the promoters' involvement and commitment to the company, investors can assess the company's governance and long-term stability.

Shareholders - Kopran Limited

The shareholders of Kopran Limited are an essential part of the company's ownership structure. Our website offers insights into the major shareholders of Kopran Limited, including institutional investors, mutual funds, and individual investors. By studying the shareholder composition, investors can gain insights into the market perception of the company and identify influential stakeholders who may impact the company's strategic decisions.

In conclusion, the content above provides a comprehensive analysis of Kopran Limited's stock, catering to long-term stock investors seeking detailed information about the company. By utilizing our pre-built screening tools and premium features, investors can access valuable resources such as annual reports, concall transcripts, investor presentations, and more, enabling them to make well-informed investment decisions.

Read More
X